The IMCAS World Congress is one of the most prestigious and influential conferences in the fields of plastic surgery and dermatology. This global event attracts medical aesthetics professionals from over 100 countries and regions, serving as a premier platform for exchanging cutting-edge technologies, sharing clinical experiences, and discussing industry trends in plastic surgery, dermatology, and anti-aging medicine.
IMCAS 2025 was held in Paris from January 30 to February 1. As a leading manufacturer of absorbable biomaterials in China, Singclean Medical proudly showcased its latest innovative products, demonstrating its exceptional quality and pioneering technology to medical professionals worldwide.
IMCAS 2025
At IMCAS 2025, Singclean Medical presented its flagship products-Singfiller bi-phasic dermal filler and Singderm mono-phasic dermal filler-alongside its latest innovation, the Singderm Dual Calcium Hydroxyapatite Hybrid Filler. This groundbreaking product offers dual benefits: the hyaluronic acid (HA) component provides immediate volumizing effects, while the calcium hydroxyapatite (CaHA) stimulates collagen regeneration for long-lasting skin elasticity and rejuvenation.
A key highlight of the event was a special session featuring Dr. You Xi from Guo Zheng Qing Yi, who provided an in-depth analysis of the advantages of Singfiller. She shared her extensive clinical experience, showcased plastic surgery injection cases, and discussed aesthetic concepts. Engaging in meaningful discussions with international practitioners, Dr. You explored the similarities and differences between Chinese and Western aesthetic standards. Her insights, backed by real case studies, captivated a wide audience of industry professionals.
Throughout IMCAS 2025, Singclean Medical's sales team engaged in in-depth discussions with industry experts and potential partners, exploring new collaboration opportunities and establishing preliminary cooperation agreements. Attending this esteemed event not only expanded Singclean Medical's presence in the international market but also reinforced its brand influence in the global medical aesthetics industry.
Looking ahead, Singclean Medical remains committed to technological innovation and quality enhancement, striving to provide safer and more effective medical aesthetics solutions for consumers worldwide. We look forward to deepening our collaboration with IMCAS and continuing our journey of innovation and excellence in the field of medical aesthetics.